Branded Generics Market Forecast to 2026

Definition: Global Branded Generics Market

Branded generic can be defined as those pharmaceutical drugs that have been re-released with a different brand name.
These drugs are produced by various pharmaceutical manufacturing companies as the patent of this drug has already expired and the generic drugs are sold at a lower cost.
Even though, there isn’t any difference in the quality or manufacturing process of the drug.

Market Analysis: Global Branded Generics Market

According to DataBridgeMarketResearch Global Branded Generics Market is expected to rise from its initial estimated value of USD 232.83 billion in 2018 to a projected value of USD 421.15 billion by 2026, registering a CAGR of 7.69% in the forecast period of 2019-2026.
This rise in market value can be attributed to growing need for cheaper treatment options and pharmaceutical drugs required by patients.
Market Drivers:
  • Growth in the number of patents expired and expiring for the branded drugs; this factor is one of the major factors driving the market growth
  • Growth in the incidents and population suffering from chronic diseases and disorders; this factor is expected to drive the market growth
Market Restraint:
  • Lack of penetration associated with the number of generic drugs worldwide; this factor is expected to act as a restraint to the market growth.

Segmentation: Global Branded Generics

  • By Product Type
  • By Therapeutic Application
  • By Drug Class
  • By Consumption
  • By Distribution Channel
  • By Geography

Competitive Analysis:

Global branded generics market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market.

Competitive Analysis:  Branded Generics

Global branded generics market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market.
The report includes market shares of branded generics market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Key Competitors: Global Branded Generics

  • Teva Pharmaceutical Industries Ltd.
  • Zydus Cadila
  • Hetero
  • AstraZeneca
  • Mylan N.V.
  • Novartis AG
  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Aspen Holdings
  • Bausch Health
  • Eris Lifesciences Limited
  • Par Pharmaceutical
CONTACT US:
USA Number – +1 888 387 2818 (Toll – Free)
Email : sopan.gedam@ databridgemarketresearch.com
Website :https://databridgemarketresearch.com

Comments

Popular posts from this blog

Global Mass spectrometry Market – Industry Trends & Forecast to 2026

Global Smart Transportation Market – Industry Trends and Forecast to 2026

Global Ostomy Drainage Bags Market